Endonovo Therapeutics

Endonovo Therapeutics

Endonovo Therapeutics

Developing Innovative Bioelectronic Therapies & Products(Following and/or retweets do not constitute an endorsement)
Founded
2011
Raised
$15.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$5,000,000
Post-IPO debt - 2016
$10,000,000
Post-IPO equity - 2016
Team Size
10+
Employees
$5,000,000 Post-IPO debt
MassDevice

Anonymous strategic investor puts another $5m into Endonovo’s Immunotronics

$10,000,000 Post-IPO equity
MassDevice

Endonovo Therapeutics raises $10m for Rio Grande buy